UPV spin off receives one million euros for the development of ACORYS, a medical device designed to improve the effectiveness and treatment of Atrial Fibrillation.

Corify Care, a spin off company of the Polytechnic University of Valencia (UPV), has obtained a one million euros grant from the Research and Development Centre for Industrial Technology Development (CDTI) of the Spanish Ministry of Science and Innovation.

This grant will be destinated for the development of ACORYS, a medical device that, using technology created by the Hospital General Universitario Gregorio Marañón and the UPV, enhances the effectiveness and non-invasive treatment of atrial fibrillation, a cardiac arrhythmia that affects more than 10 million people just across Europe.

Link to "El español"
Link to "Apunt" Video
Link to "Innospain"
Link to "La Sexta"
Link to "Cadena Ser"
Link to "News Medical"

Related posts
Hospital Gregorio Marañón Launches Pioneering Clinical Trial for Complex AF Using Novel Corify-Guided Ablation Strategy

The Hospital Gregorio Marañón, a world-renowned leader in cardiology, has launched a new prospective clinical trial to tackle one of the toughest...

Read More »
World heart Day – 2200 patients mapped

This World Heart Day, 29th of September 2025, we’re celebrating a milestone that matters: more than 2,200 hearts mapped with our technology. ...

Read More »
CARE-ECGI: Transforming cardiac pacing through noninvasive mapping and AI

At Corify Care, we are proud to coordinate CARE-ECGI, a national R&D project focused on advancing noninvasive mapping to support cardiac pacing...

Read More »